Anna Grifa

Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus.

factors1. Mutations in the connexin26 gene (GJB2), located on 13q12, are responsible for non-syndromic recessive and dominant forms of deafness2–4. Connexin-31 and connexin-32 have also been implicated in deafness5,6. The identification of deaf families linked to 13q12 but negative for mutations in GJB2 (ref. 7) suggested the presence of other deafness genes in this region. Recently, the mouse connexin-30 gene (Gjb6), which is expressed in cochlea, has been mapped to a region with syntenic homology to human chromosome 13q12 (refs 8,9). To verify if human GJB6 is involved in deafness, we cloned a 1,799-bp cDNA fragment containing an ORF of 261 amino acids (EMBL HSA005585). CX30 protein has a structure similar to that of other connexins10 and shares 93% homology with mouse Cx30 and 76% identity with human CX26. GJB6 is not interrupted by introns and maps to chromosome 13q12, approximately 800 kb centromeric to GJB2. SSCP mutational analysis in 198 deaf patients, including 38 families linked to 13q12, revealed a threonine-to-methionine change at position 5 (T5M) in an Italian family affected by bilateral middle/ high-frequency hearing loss (Fig. 1a–c). Audiograms in T5M family members showed a 20–50-dB decrease at frequencies of 2,000–8,000 Hz (I-2), a progressive impaired threshold above 500 Hz (II-1) and a profound sensorineural deafness (II-2). This variability of hearing impairment can be explained by a different expressivity of the disease, which is almost the rule for dominant deafness. Northern blots, RT-PCR and in situ hybridization on mouse embryos revealed Gjb6 expression in trachea, thyroid, thymus, brain and cochlea, confirming reported expression patterns (refs 8,9,11). The threonine residue at position 5 is evolutionarily conserved and also present in human connexin 26 (Fig. 1d). The T5M substitution abolishes a hydrophilic residue possibly involved in interor Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus correspondence

The motilin gene: subregional localisation, tissue expression, DNA polymorphisms and exclusion as a candidate gene for the HLA-associated immotile cilia syndrome

The product of the human motilin gene (MLN) has an important role in regulating gastrointestinal motility. The precise chromosomal localisation and expression of this gene are still unresolved. Here, we report a detailed study assigning MLN to 6p21.3; MLN is tightly linked to the HLA-DQalpha locus. Moreover, MLN expression has been evaluated in a large series of tissues. Positive signals have been obtained for brain, bronchi and a gastrointestinal malignancy. Direct sequencing exon by exon of the codifying region, intron/exon boundaries and promoter has allowed the identification of three DNA polymorphisms, one of which corresponds to a common protein variant. The chromosomal localisation of MLN, and its expression in broncoepithelial cells suggests that this gene is involved in immotile-cilia syndrome (ICS) disease. Sequence and segregation analysis of the MLN gene carried out in two families, in which the disease locus was previously assigned to 6p21.3, exclude MLN as a candidate gene for the HLA-associated form of ICS.

Generation of a transcription map of a 1 Mbase region containing the HFE gene (6p22)

A transcription map was generated of a 1 Mb interval including the HFE gene on 6p22. Thirty-seven unique cDNA fragments were characterised following their retrieval from hybridisation of immobilised YACs to primary pools of cDNAs prepared from RNA of foetal brain, human liver, foetal human liver, placenta, and CaCo2 cell line. All cDNA fragments were positioned on the physical map on the basis of presence in aligned and overlapping YACs and cosmid clones of the region. The isolated cDNAs together with established or published sequence tagged sites (STSs) and markers provided sufficient landmark density to cover approximately 90% of the 1 Mb interval with cosmid clones. The precise localisation of two known genes (NPT1 and RING finger protein) was established. A minimum of 14 additional transcription units has also been integrated. Twenty-eight cDNA fragments showed no similarity with known sequences, but 20 of these detected discrete mRNAs upon northern analysis. Their characterisation is still under investigation. Eleven new polymorphisms were also identified and localised, and the HFE genomic structure was better defined. This integrated transcription map considerably extends a recently published map of the HFE region. It will be useful for the identification of genetic defects mapping to this region and for providing template resources for genomic sequencing.

A new complex polymorphic repeat close to the HLA-A and HLA-E loci

We describe a complex polymorphic repeat discovered analyzing YAC 225B1, which spans the region between the HLA-A and HLA-E loci. The repeat consists of a variable number of the nucleotide A followed by a variable number of the trinucleotide AAG [(A)n(AAG)n]. Three different alleles were detected with an observed heterozygosity of 0.30.